HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,219,329 | -69.1% | 144,700 | -67.3% | 0.01% | -70.5% |
| Q1 2023 | $16,918,170 | -50.1% | 443,000 | -25.7% | 0.04% | -53.7% |
| Q4 2022 | $33,918,090 | +158.7% | 596,100 | +79.8% | 0.10% | +150.0% |
| Q3 2022 | $13,111,000 | -23.6% | 331,600 | -15.0% | 0.04% | -22.4% |
| Q2 2022 | $17,169,000 | +7332.5% | 390,200 | +6627.6% | 0.05% | +4800.0% |
| Q1 2022 | $231,000 | -98.2% | 5,800 | -98.2% | 0.00% | -97.1% |
| Q3 2021 | $12,941,000 | -46.8% | 318,120 | -40.6% | 0.03% | -46.9% |
| Q2 2021 | $24,332,000 | +32.5% | 535,820 | +21.7% | 0.06% | +28.0% |
| Q1 2021 | $18,361,000 | +3.7% | 440,420 | +6.2% | 0.05% | +6.4% |
| Q4 2020 | $17,708,000 | -38.6% | 414,620 | -62.2% | 0.05% | -42.7% |
| Q3 2020 | $28,845,000 | -26.6% | 1,097,620 | -25.1% | 0.08% | -28.7% |
| Q2 2020 | $39,275,000 | +43.1% | 1,464,920 | -4.0% | 0.12% | +9.5% |
| Q1 2020 | $27,453,000 | +57.0% | 1,526,020 | +54.7% | 0.10% | +156.1% |
| Q4 2019 | $17,487,000 | +222.3% | 986,320 | +182.0% | 0.04% | +215.4% |
| Q3 2019 | $5,426,000 | -5.1% | 349,820 | +5.1% | 0.01% | -7.1% |
| Q2 2019 | $5,716,000 | +22.1% | 332,720 | +14.4% | 0.01% | +16.7% |
| Q1 2019 | $4,681,000 | -29.7% | 290,720 | -36.1% | 0.01% | -33.3% |
| Q4 2018 | $6,657,000 | -50.2% | 455,020 | -38.2% | 0.02% | -45.5% |
| Q3 2018 | $13,375,000 | -15.9% | 736,120 | -21.9% | 0.03% | -23.3% |
| Q2 2018 | $15,900,000 | -25.8% | 942,520 | -13.8% | 0.04% | -25.9% |
| Q1 2018 | $21,422,000 | +50.9% | 1,093,520 | +56.1% | 0.06% | +52.6% |
| Q4 2017 | $14,197,000 | +540.4% | 700,720 | +449.1% | 0.04% | +533.3% |
| Q3 2017 | $2,217,000 | +480.4% | 127,620 | +328.0% | 0.01% | +500.0% |
| Q2 2017 | $382,000 | +134.4% | 29,820 | +136.7% | 0.00% | 0.0% |
| Q1 2017 | $163,000 | -40.9% | 12,600 | -20.9% | 0.00% | -50.0% |
| Q4 2015 | $276,000 | -57.4% | 15,920 | -66.4% | 0.00% | -50.0% |
| Q3 2015 | $648,000 | +103.1% | 47,424 | +235.9% | 0.00% | +100.0% |
| Q2 2015 | $319,000 | – | 14,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |